Global brain and spinal cord cancer market, size, share, market intelligence, company profiles, market trends, growth, strategy, research and analysis report, forecast 2018-2023
Brain and spinal cord cancer market is expected to high growth during 2018-2023 due to high incidence rate of brain and spinal cord cancer in the US and rising demand for minimally invasive surgeries across the globe. Brain tumors account for 85% to 90% of all primary central nervous system (CNS) tumors. Epidemiology, and End Results (SEER) database for 2011 indicate that the combined incidence of primary invasive CNS tumors in the US is 6.4 per 100,000 persons per year, with an estimated mortality of 4.3 per 100,000 persons per year. Globally, approximately 260 thousand new cases of brain and other CNS tumors were diagnosed in the year 2015, with an estimated 190 thousand deaths. Many countries are performing research and developments for the treatment of the brain and spinal cord cancer across the globe. The European Organisation for Research and Treatment of Cancer (EORTC) randomly assigned 311 patients with low-grade gliomas to undergo either radiation or observation in the EORTC-22845 (MRC BR04) trial. On review of central pathology, about 25% of patients in the trial were reported to have high-grade tumors. Most of the control patients received radiation therapy at the time of progression.